SPHERA FUNDS MANAGEMENT LTD. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$4,780,000
+32.9%
216,980
+8.5%
0.42%
+19.8%
Q3 2020$3,598,000
-55.7%
199,980
-64.6%
0.35%
-71.7%
Q3 2019$8,113,000
+63.7%
565,000
+79.6%
1.25%
+84.8%
Q2 2019$4,956,000
+70.2%
314,642
+78.0%
0.68%
+36.7%
Q4 2014$2,912,000176,8020.50%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders